The in-vitro sensitivity of 32 strains of Mycobacterium ulcerans to rifampicin was found to be similar to that of Myco
. tuberculosis. A 1-mth course of rifampicin in three different dosage regimens was used to treat experimental Myco. ulcerans infection of mouse foot-pads starting 2 and 5 wk after infection. Each regimen led to clinical improvement, but the disease relapsed 6–8 wk after completion of therapy. Treatment of severe lesions for 10 wk produced apparent cure. A 1-mth course of sulphadoxine plus pyrimethamine or of clofazimine proved ineffective, and combination of these with rifampicin were no more effective than rifampicin alone.
CruickshankR.,
StewartSheila M.1961; Detection of resistance to Streptomycin, P.A.S. and Isoniazid in tubercle bacilli. Assoc. Clin. Path. Broadsheet no. 32 (new series). London
LeachR. H.,
FennerF.1954; Studies of Mycobacterium ulcerarts and Mycobacterium balnei. III. Growth in semi-synthetic culture media of Dubos and drug sensitivity in vitro and in vivo. Austral. J. Exp. Biol. Med. Sci. 32:835
PattynS. R.,
RoyackersJ.1965; Traitement de l’infection expérimentale de la souris par Mycobacterium ulcerans et Mycobacterium balnei.. Annls Soc. beige Med. trop. 45:31